Share on:

Department and Faculty

Photo of Kurt A. Kennel, M.D.; Neena Natt, M.D.; and Michael D. Jensen, M.D.

Kurt A. Kennel, M.D., fellowship director; Neena Natt, M.D., vice chair for education and immediate past fellowship director; and Michael D. Jensen, M.D., principal investigator of the Endocrinology, Diabetes and Metabolism NIH T32 training grant.

The Division of Endocrinology, Diabetes, Metabolism, & Nutrition at Mayo Clinic is the largest unified practice of its kind in the United States. In any given year, members of the division handle more than 14,000 patient visits.

The division is organized around interest groups oriented toward disease processes, specific glands or patient groups. Clinical expertise is integrated with the newest forms of established and experimental diagnostic and therapeutic methods. Patient care is provided by teams of physicians and other health care staff with broad expertise in all forms of endocrine and metabolic disorders.

Because of our recognition that high-quality care depends upon scientific discovery, major research programs at the basic, translational and applied levels exist to generate new knowledge that improves how we care for our patients. Mayo Clinic has a National Institutes of Health-funded T32 training grant in endocrinology, diabetes and metabolism.

Areas of clinical and research expertise offered in the Division of Endocrinology, Diabetes, Metabolism, & Nutrition include:

  • Clinical nutrition. Emphasis on obesity, bariatric surgery, malnutrition, and enteral and parenteral nutrition in the hospital setting.
  • Inpatient endocrinology. Metabolic management of inpatients and management of endocrine disease in the perioperative setting.
  • Thyroid. Thyroid dysfunction and related complications (such as Graves' ophthalmopathy), diagnostic thyroid ultrasound and fine-needle aspiration of thyroid nodules, and management of low-risk thyroid cancer.
  • Adrenal disease. Congenital or acquired disorders of hyperfunction, including primary hyperaldosteronism, pheochromocytoma and Cushing syndrome.
  • Pituitary gonadal disease. Medical management of prolactinoma, acromegaly, hypogonadism and diabetes insipidus.
  • Endocrine neoplasia. Including advanced thyroid cancer, adrenal cancers, neuroendocrine tumors, multiple endocrine neoplasia, and other syndromes in coordination with oncology and related specialties.
  • Bone and calcium. Osteoporosis pathophysiology, cancer-induced bone disease, hypoparathyroidism and primary hyperparathyroidism.
  • Metabolic disorders. Technology and algorithms for insulin pumps, glucose sensor loops, lipid metabolism as it relates to cardiac disease, polycystic ovary syndrome, lipodystrophy, and hypoglycemic disorders.
  • Transplant. Whole-pancreas and islet cell transplantation and post-transplant endocrinology.
  • Aging. Endocrine physiology in aging.
  • Sep 30, 2014
  • ART896985